1 recruiting, 1 unknown. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Cyclosporine ophthalmic solution 0.1%: new trials by email Literature Review of Cyclosporine ophthalmic solution 0.1% trials Research Report on Cyclosporine ophthalmic solution 0.1%
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Real-World Assessment of VEVYE® for Short-Term Symptom and Sign Improvement of Dry Eye Disease in a Neuro-Ophthalmology Clinic: A 6-Month Prospective Observational Study Cyclosporine ophthalmic solution 0.1% - Dry Eye | Recruiting | Neuro-Ophthalmology of Texas | 50 | 2026-03-31 | 2026-05-05 | |
| Evaluation of Safety & Efficacy for the Prevention of Ocular GVHD With Ophthalmic Tacrolimus vs Cyclosporine in Allo-HSCT Cyclosporine ophthalmic solution 0.1%, Tacrolimus ophthalmic ointment 0.03% - Ocular Graft-versus-host Disease | Phase 1 / Phase 2 | Unknown | Hospital Universitario Dr. Jose E. Gonzalez | 60 | 2023-08-01 | 2024-04-08 |
Hospital Universitario Dr. Jose E. Gonzalez (1) · Neuro-Ophthalmology of Texas (1)
Mexico (1) · United States (1)
Rosa A. Tang (1)